The prognostic significance of thrombocytosis in uterine papillary serous carcinomas

Gynecologic Oncology

Volumn 104, Issue 1, 2007, Pages 91-94

  Lerner, Dimitry L ^a   Walsh, Christine S ^a   Cass, Ilana ^a   Karlan, Beth Y ^a   Li, Andrew J ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Thrombocytosis; Uterine papillary serous carcinomas

Indexed keywords

PLATELET DERIVED GROWTH FACTOR;

ADULT; ADVANCED CANCER; ARTICLE; ASCITES; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE FREE INTERVAL; FEMALE; HISTOPATHOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PHENOTYPE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOCYTOSIS; TUMOR GROWTH; UTERUS CARCINOMA;

CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; INCIDENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; THROMBOCYTOSIS; UTERINE NEOPLASMS;

EID: 33846012553     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.07.020     Document Type: Article

References (27)

1. Naschitz J.E., Heshurun D., Eldar S., and Lev L.M. Diagnosis of cancer-associated vascular disorders. Cancer 77 (1996) 1759-1767
2. Pedersen L.M., and Milman N. Diagnostic significance of platelet count and other blood analyses in patients with lung cancer. Oncol. Rep. 10 (2003) 213-216
3. O'Keefe S.C., Marshall F.F., Issa M.M., Harmon M.P., and Petros J.A. Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J. Urol. 168 (2002) 1378-1380
4. Ikeda M., Furukawa H., Imamura H., Shimizu J., Ishida H., Masutani S., et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann. Surg. Oncol. 9 (2002) 287-291
5. Benoy I., Salgado R., Colpaert C., Weytjens R., Vermeulen P.B., and Dirix L.Y. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clin. Breast Cancer 2 (2002) 311-315
6. Schwarz R.E., and Keny H. Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma. Hepatogastroenterology 48 (2001) 1493-1498
7. Costantini V., Zacharski L.R., Moritz T.E., and Edwards R.L. The platelet count in carcinoma of the lung and colon. Thromb Haemost. 64 (1990) 501-505
8. Tamussino K.F., Gucer F., Reich O., Moser F., Petru E., and Scholz H.S. Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int. J. Gynecol. Cancer 11 (2001) 236-240
9. Scholz H.S., Petru E., Gucer F., Haas J., Tamussino K., and Winter R. Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res. 20 (2000) 3983-3985
10. Gucer F., Moser F., Tamussino K., Reich O., Haas J., Arikan G., et al. Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol. Oncol. 70 (1998) 210-214
11. Hefler L., Mayerhofer K., Leibman B., Obermair A., Reinthaller A., Kainz C., et al. Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol. 21 (2000) 309-314
12. Lavie O., Comerci G., Daras V., Bolger B.S., Lopes A., and Monaghan J.M. Thrombocytosis in women with vulvar carcinoma. Gynecol. Oncol. 72 1 (1999) 82-86
13. Hernandez E., Donohue K.A., Anderson L.L., Heller P.B., and Stehman F.B. The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol. 78 (2000) 137-142
14. Li A.J., Madden A.C., Cass I., Leuchter R.S., Lagasse L.D., and Karlan B.Y. The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol. Oncol. 92 1 (2004) 211-214
15. Tranum B.L., and Haut A. Thrombocytosis: platelet kinetics in neoplasia. J. Lab. Clin. Med. 84 (1974) 615-619
16. Gastl G., Plante M., Finstad C.L., Wong G.Y., Federici M.G., Bander N.H., et al. High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Brit. J. Haematol. 83 (1993) 433-441
17. Dabrow M.B., Francesco M.R., McBrearty F.X., and Caradonna S. The effect of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium. Gynecol. Oncol. 71 (1998) 29-37
18. Qian X., and Tuszynski G.P. Expression of thrombospondin-1 in cancer: a role in tumor progression. Proc. Soc. Exp. Biol. Med. 212 (1996) 199-207
19. Arnoletti J.P., Albo D., Granick M.S., Solomon M.P., Castiglioni A., Rothman V.L., et al. Thrombospondin and transforming growth factor-beta1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitior-1 in human MDA-MB-231 breast cancer cells. Cancer 76 (1995) 998-1005
20. Bristow R.E., Asrari F., Trimble E.L., and Montz F.J. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (stage I-III) disease. Gynecol. Oncol. 81 2 (2001) 279-286
21. Miller B., Umpierre S., Tornos C., and Burke T. Histologic characterization of uterine papillary serous adenocarcinoma. Gynecol. Oncol. 56 3 (1995) 425-429
22. Resnik E., and Taxy J.B. Neoadjuvant chemotherapy in uterine papillary serous carcinoma. Gynecol Oncol. 62 1 (1996) 123-127
23. Zeimet A.G., Marth C., Muller-Holzner E., Daxenbichler G., and Dapunt O. Significance of thrombocytosis in patients with epithelial ovarian cancer. Am. J. Obstet. Gynecol. 170 (1994) 549-554
24. Menczer J., Schejter E., Geva D., Ginath S., and Zakut H. Ovarian carcinoma associated thrombocytosis: correlation with prognostic factors and with survival. Eur. J. Gynaecol. Oncol. 12 (1998) 82-84
25. Chalas E., Welshinger M., Engellener W., Chumas J., Barbieri R., and Mann W.J. The clinical significance of thrombocytosis in women presenting with a pelvic mass. Am. J. Obstet. Gynecol. 166 (1992) 974-977
26. Gucer F., Moser F., Tamussino K., Reich O., Haas J., Arikan G., et al. Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol. Oncol. 70 2 (1998) 210-214
27. Tamussino K.F., Gucer F., Reich O., Moser F., Petru E., and Scholz H.S. Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int. J. Gynecol. Cancer 11 3 (2001) 236-240